Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CVS
US Stock Futures Surge Ahead Of Economic Data
CVS Health Tops Q1 Expectations
The Vetr community has upgraded $CVS to 3-Stars. (Vetr)
Related RM
After-Hours Market Movers Led By Urban Outfitters, United Natural Foods & 21Vianet On Monday
Earnings Scheduled For March 9, 2015

Analysts at Cantor Fitzgerald downgraded CVS (NYSE: CVS) from “buy” to “hold.” The target price for CVS has been lowered from $65 to $62. CVS's shares closed at $59.89 yesterday.

Jefferies downgraded Regional Management (NYSE: RM) from “buy” to “hold.” The target price for Regional Management is set to $29. Regional Management's shares closed at $31.20 yesterday.

Bank of America downgraded Marathon Oil (NYSE: MRO) from “buy” to “neutral.” The target price for Marathon Oil has been lowered from $45 to $42. Marathon Oil's shares closed at $36.88 yesterday.

Analysts at McNicoll Lewis Vlak downgraded ACADIA Pharmaceuticals (NASDAQ: ACAD) from “buy” to “hold.” The target price for ACADIA Pharmaceuticals has been raised from $18 to $20. ACADIA's shares closed at $20.68 yesterday.

Latest Ratings for CVS

DateFirmActionFromTo
Apr 2015JefferiesMaintainsBuy
Feb 2015Deutsche BankMaintainsHold
Feb 2015CitigroupMaintainsNeutral

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ACAD + CVS)

Around the Web, We're Loving...